Reply to R. Saude Conde et al

Yukihide Kanemitsu¹

Affiliations

PMID: 35025609
DOI: 10.1200/JCO.21.02713

Comment

Reply to R. Saude Conde et al

Yukihide Kanemitsu. J Clin Oncol. 2022.

. 2022 Mar 1;40(7):805-806.

doi: 10.1200/JCO.21.02713. Epub 2022 Jan 13.

Author

Yukihide Kanemitsu¹

Affiliation

¹ Yukihide Kanemitsu, MD, National Cancer Center Hospital, Tokyo, Japan.

PMID: 35025609
DOI: 10.1200/JCO.21.02713

No abstract available

PubMed Disclaimer

Conflict of interest statement

Yukihide KanemitsuHonoraria: Chugai Pharma, Ethicon, Covidien, Intuitive SurgicalConsulting or Advisory Role: CovidienNo other potential conflicts of interest were reported.

Comment on

Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial.
Kanemitsu Y, Shimizu Y, Mizusawa J, Inaba Y, Hamaguchi T, Shida D, Ohue M, Komori K, Shiomi A, Shiozawa M, Watanabe J, Suto T, Kinugasa Y, Takii Y, Bando H, Kobatake T, Inomata M, Shimada Y, Katayama H, Fukuda H; JCOG Colorectal Cancer Study Group. Kanemitsu Y, et al. J Clin Oncol. 2021 Dec 1;39(34):3789-3799. doi: 10.1200/JCO.21.01032. Epub 2021 Sep 14. J Clin Oncol. 2021. PMID: 34520230 Clinical Trial.
JCOG0603: Are We Really Sure This Was a Negative Trial?
Saude Conde R, Bregni G, Saad E, Hendlisz A, Sclafani F. Saude Conde R, et al. J Clin Oncol. 2022 Mar 1;40(7):803-805. doi: 10.1200/JCO.21.02299. Epub 2022 Jan 13. J Clin Oncol. 2022. PMID: 35025615 No abstract available.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply to R. Saude Conde et al

Affiliation

Reply to R. Saude Conde et al

Author

Affiliation

Conflict of interest statement

Comment on

Publication types

LinkOut - more resources

Full Text Sources